Identification of microRNAs as diagnostic biomarkers in screening of head and neck cancer: A meta-analysis

Genetics and Molecular Research

Volumn 14, Issue 4, 2015, Pages 16562-16576

  Zhang, M ^a   Zhao, L J ^a   Liang, W Q ^b   Mao, Z P ^a  

^a Shaoxing Second Hospital   (China)

^b ZHEJIANG UNIVERSITY   (China)

Author keywords

Head and neck cancer; Meta analysis; MicroRNAs; Screening

Indexed keywords

BIOLOGICAL MARKER; MICRORNA; TUMOR MARKER;

AREA UNDER THE CURVE; ARTICLE; ASIAN; CANCER SCREENING; CAUCASIAN; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; ESOPHAGUS CANCER; FEMALE; GENE EXPRESSION; HEAD AND NECK CANCER; HUMAN; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; MOUTH CANCER; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; THYROID CANCER; BLOOD; CASE CONTROL STUDY; HEAD AND NECK TUMOR; METABOLISM;

BIOMARKERS, TUMOR; CASE-CONTROL STUDIES; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MICRORNAS;

EID: 84949811685     PISSN: None     EISSN: 16765680     Source Type: Journal    
DOI: 10.4238/2015.December.11.3     Document Type: Article

References (36)

1. Avissar M, Christensen BC, Kelsey KT and Marsit CJ (2009). MicroRNA expression ratio is predictive of head and neck squamous cell carcinoma. Clin. Cancer Res. 15: 2850-2855.
2. Du T and Zamore PD (2007). Beginning to understand microRNA function. Cell Res. 17: 661-663.
3. Glas AS, Lijmer JG, Prins MH, Bonsel GJ, et al. (2003). The diagnostic odds ratio: a single indicator of test performance. J. Clin. Epidemiol. 56: 1129-1135.
4. Gombos K, Horvath R, Szele E, Juhasz K, et al. (2013). miRNA expression profiles of oral squamous cell carcinomas. Anticancer Res. 33: 1511-1517.
5. Hardisson D (2003). Molecular pathogenesis of head and neck squamous cell carcinoma. Eur. Arch. Otorhinolaryngol. 260: 502-508.
6. Hirajima S, Komatsu S, Ichikawa D, Takeshita H, et al. (2013). Clinical impact of circulating miR-18a in plasma of patients with oesophageal squamous cell carcinoma. Br. J. Cancer 108: 1822-1829.
7. Jemal A, Siegel R, Ward E, Hao Y, et al. (2008). Cancer statistics, 2008. CA Cancer J. Clin. 58: 71-96.
8. Keutgen XM, Filicori F, Crowley MJ, Wang Y, et al. (2012). A panel of four miRNAs accurately differentiates malignant from benign indeterminate thyroid lesions on fine needle aspiration. Clin. Cancer Res. 18: 2032-2038.
9. Kitano M, Rahbari R, Patterson EE, Xiong Y, et al. (2011). Expression profiling of difficult-to-diagnose thyroid histologic subtypes shows distinct expression profiles and identify candidate diagnostic microRNAs. Ann. Surg. Oncol. 18: 3443-3452.
10. Kitano M, Rahbari R, Patterson EE, Steinberg SM, et al. (2012). Evaluation of candidate diagnostic microRNAs in thyroid fine-needle aspiration biopsy samples. Thyroid 22: 285-291.
11. Kloosterman WP and Plasterk RH (2006). The diverse functions of microRNAs in animal development and disease. Dev. Cell 11: 441-450.
12. Komatsu S, Ichikawa D, Takeshita H, Tsujiura M, et al. (2011). Circulating microRNAs in plasma of patients with oesophageal squamous cell carcinoma. Br. J. Cancer 105: 104-111.
13. Liu CJ, Kao SY, Tu HF, Tsai MM, et al. (2010). Increase of microRNA miR-31 level in plasma could be a potential marker of oral cancer. Oral Dis. 16: 360-364.
14. Liu SS, Wang YS, Sun YF, Miao LX, et al. (2014). Plasma microRNA-320, microRNA-let-7e and microRNA-21 as novel potential biomarkers for the detection of retinoblastoma. Biomed Rep. 2: 424-428.
15. Liu X, Luo HN, Tian WD, Lu J, et al. (2013). Diagnostic and prognostic value of plasma microRNA deregulation in nasopharyngeal carcinoma. Cancer Biol. Ther. 14.
16. Lu YC, Chen YJ, Wang HM, Tsai CY, et al. (2012). Oncogenic function and early detection potential of miRNA-10b in oral cancer as identified by microRNA profiling. Cancer Prev. Res. 5: 665-674.
17. Maclellan SA, Lawson J, Baik J, Guillaud M, et al. (2012). Differential expression of miRNAs in the serum of patients with high-risk oral lesions. Cancer Med. 1: 268-274.
18. Mazeh H, Mizrahi I, Halle D, Ilyayev N, et al. (2011). Development of a microRNA-based molecular assay for the detection of papillary thyroid carcinoma in aspiration biopsy samples. Thyroid 21: 111-118.
19. Miska EA (2005). How microRNAs control cell division, differentiation and death. Curr. Opin. Genet. Dev. 15: 563-568.
20. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, et al. (2008). Circulating microRNAs as stable blood-based markers for cancer detection. Proc. Natl. Acad. Sci. U. S. A. 105: 10513-10518.
21. Ouyang SB, Wang J, Huang ZK and Liao L (2013). Expression of microRNA-31 and its clinicopathologic significance in oral squamous cell carcinoma. Zhonghua Kou Qiang Yi Xue Za Zhi. 48: 481-484.
22. Parkin DM (2001). Global cancer statistics in the year 2000. Lancet Oncol. 2: 533-543.
23. Ries J, Vairaktaris E, Agaimy A, Kintopp R, et al. (2014). miR-186, miR-3651 and miR-494: potential biomarkers for oral squamous cell carcinoma extracted from whole blood. Oncol. Rep. 31: 1429-1436.
24. Sheinerman KS, Tsivinsky VG and Umansky SR (2013). Analysis of organ-enriched microRNAs in plasma as an approach to development of Universal Screening Test: feasibility study. J. Transl. Med. 11: 304.
25. Shen R, Liyanarachchi S, Li W, Wakely PE Jr, et al. (2012). MicroRNA signature in thyroid fine needle aspiration cytology applied to “atypia of undetermined significance” cases. Thyroid 22: 9-16.
26. Skog J, Wurdinger T, van Rijn S, Meijer DH, et al. (2008). Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat. Cell Biol. 10: 1470-1476.
27. Stefani G and Slack FJ (2008). Small non-coding RNAs in animal development. Nat. Rev. Mol. Cell Biol. 9: 219-230.
28. Takeshita N, Hoshino I, Mori M, Akutsu Y, et al. (2013). Serum microRNA expression profile: miR-1246 as a novel diagnostic and prognostic biomarker for oesophageal squamous cell carcinoma. Br. J. Cancer 108: 644-652.
29. Valadi H, Ekstrom K, Bossios A, Sjostrand M, et al. (2007). Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat. Cell Biol. 9: 654-659.
30. Vriens MR, Weng J, Suh I, Huynh N, et al. (2012). MicroRNA expression profiling is a potential diagnostic tool for thyroid cancer. Cancer 118: 3426-3432.
31. Wang Y, Chen M, Tao Z, Hua Q, et al. (2013). Identification of predictive biomarkers for early diagnosis of larynx carcinoma based on microRNA expression data. Cancer Genet. 206: 340-346.
32. Zeng X, Xiang J, Wu M, Xiong W, et al. (2012). Circulating miR-17, miR-20a, miR-29c, and miR-223 combined as non-invasive biomarkers in nasopharyngeal carcinoma. PLoS One 7: e46367.
33. Zhang C, Wang C, Chen X, Yang C, et al. (2010). Expression profile of microRNAs in serum: a fingerprint for esophageal squamous cell carcinoma. Clin. Chem. 56: 1871-1879.
34. Zhang T, Wang Q, Zhao D, Cui Y, et al. (2011). The oncogenetic role of microRNA-31 as a potential biomarker in oesophageal squamous cell carcinoma. Clin. Sci. 121: 437-447.
35. Zhang T, Zhao D, Wang Q, Yu X, et al. (2013). MicroRNA-1322 regulates ECRG2 allele specifically and acts as a potential biomarker in patients with esophageal squamous cell carcinoma. Mol. Carcinog. 52: 581-590.
36. Zhou SL and Wang LD (2010). Circulating microRNAs: novel biomarkers for esophageal cancer. World J. Gastroenterol. 16: 2348-2354.